Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.
Corvus Pharmaceuticals, Inc. jumps 165% on Phase 1 soquelitinib atopic dermatitis data; learn key efficacy, funding, and ...
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
Researchers found an antibody that seems to play a role in people with better lung cancer prognoses, but turning it into a ...
Training people to activate a part of the brain linked to reward and positive expectations may be associated with an increase ...
The team’s research provides compelling evidence for the brain’s influence on physiology. A deeper understanding of this mind ...
How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy ...
Regular exercise supports immune health by improving the circulation of your immune cells and reducing inflammation, but ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an unconventional approach to metastatic cancer: instead of going after cancer cells ...
A new study led by researchers at the Johns Hopkins Kimmel Cancer Center, its Bloomberg~Kimmel Institute for Cancer ...
The mechanism underlying how seasonal allergies recur year after year with precise timing remains largely unknown. An international team led by Professor Rudolf Valenta has identified a specific type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results